G4S Africa supports small business development thr... » The latest product in the G4S Deposita range is a smart safe system called mini-pay that holds up to... Commissioner's statement following incident in Man... » This is an utterly appalling attack. My thoughts are with the people of Manchester as they try to co... UPDATE: Policing events in the Capital » Following the horrific terrorist attack in Manchester last night, in which 22 people were killed and... Statement from Assistant Commissioner » Statement from Assistant Commissioner Mark Rowley, Head of National Counter Terrorism Policing: The... Met intensifies policing activities in London fol... » The Metropolitan Police Service (MPS) has increased police numbers and operations across the Capital... OF FOOLS OF THE MIDDLE BELT, ONE NORTH AND PASTORA... » Please visit also: www.scorpionnewscorp.com SERIES: BUHARISM AND THE FIERCE URGENCY OF NOW A treat... Home Secretary’s statement on the Manchester attac... » I know that some people will only just be waking up to the news of the horrific attacks in Mancheste... Checkpoint Systems unveils Bug Tag 2 loss preventi... » Checkpoint Systems has announced the launch of Bug Tag 2 – an innovative loss prevention solution th... Edesix launches new head and torso mounted body wo... » Edesix has announced the launch of new head and torso mounted cameras. The X-100 is a side-mounta... Banknote Watch offers essential advice as old £5 i... » As of Friday 5th May 2017, the paper £5 note was officially withdrawn from circulation and no lo...

CLICK HERE TO

SOCIAL BOOKMARK

Talking Point Banner

The media recently reported that the FDA had issued a stern warning to Abbott for failing to properly investigate and resolve cybersecurity risks and battery malfunctions for its pacemaker and defibrillator devices:

In response, IoT cybersecurity expert Rod Schultz, VP of Product, Rubicon Labs, says: "The FDA warning to Abbott is an echo of challenges we’ve seen in other technology verticals that are built with batteries and software. Every mobile device in the field today is available and affordable because of advances in those two areas. The healthcare industry must build on technology advancement to innovate, but patient safety and FDA requirements have got to be addressed as top-most priorities. The FDA works closely with federal agencies, DHS, and medical device manufacturers to increase reliability and security, but it seems that more guidance is needed, and perhaps the incentive structure needs to be changed.

 

"For this specific case, advice from a few key technology companies (Samsung, Apple, and Google) could have helped tremendously. Each of those companies has processes and advice that the FDA could solicit to prevent battery, cybersecurity, and other mobile device pitfalls - all of which are only going to become more frequent with smart medical devices. We are at the beginning of an incredible transformation in how medical care is given and received, and the FDA can probably do more than send out strongly worded letters. They have the power to proactively connect the world's technology pioneers with its health care pioneers so that the patient can benefit."